ES2183803T3 - Procedimiento para la purificacion de factor xiii, anticuerpos monoclonales contra factor xiiia, su preparacion y utilizacion. - Google Patents

Procedimiento para la purificacion de factor xiii, anticuerpos monoclonales contra factor xiiia, su preparacion y utilizacion.

Info

Publication number
ES2183803T3
ES2183803T3 ES92113176T ES92113176T ES2183803T3 ES 2183803 T3 ES2183803 T3 ES 2183803T3 ES 92113176 T ES92113176 T ES 92113176T ES 92113176 T ES92113176 T ES 92113176T ES 2183803 T3 ES2183803 T3 ES 2183803T3
Authority
ES
Spain
Prior art keywords
purification
preparation
monoclonal antibodies
antibodies against
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92113176T
Other languages
English (en)
Inventor
Johann Hock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Behring GmbH
Original Assignee
Aventis Behring GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Behring GmbH filed Critical Aventis Behring GmbH
Application granted granted Critical
Publication of ES2183803T3 publication Critical patent/ES2183803T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

SE DESCRIBE UN METODO PARA LA LIMPIEZA DEL FACTOR XIII O XIIIA POR CROMATOGRAFIA DE AFINIDAD INMUNE, ANTICUERPO MONOCLONAL CONTRA F XIIIA, SU FABRICACION Y SU EMPLEO.
ES92113176T 1991-08-22 1992-08-03 Procedimiento para la purificacion de factor xiii, anticuerpos monoclonales contra factor xiiia, su preparacion y utilizacion. Expired - Lifetime ES2183803T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4127841A DE4127841A1 (de) 1991-08-22 1991-08-22 Verfahren zur reinigung von faktor xiii, monoklonale antikoerper gegen faktor xiiia, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
ES2183803T3 true ES2183803T3 (es) 2003-04-01

Family

ID=6438873

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92113176T Expired - Lifetime ES2183803T3 (es) 1991-08-22 1992-08-03 Procedimiento para la purificacion de factor xiii, anticuerpos monoclonales contra factor xiiia, su preparacion y utilizacion.

Country Status (9)

Country Link
US (1) US5688919A (es)
EP (1) EP0529348B1 (es)
JP (1) JPH05268990A (es)
KR (1) KR100245542B1 (es)
AT (1) ATE226595T1 (es)
AU (1) AU649868B2 (es)
CA (1) CA2076557C (es)
DE (2) DE4127841A1 (es)
ES (1) ES2183803T3 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100389197B1 (ko) * 2000-03-17 2003-06-27 유지현 실내의 매연 농도에 따라 다단식으로 자동 작동되는환풍방법
US6660486B2 (en) * 2001-05-31 2003-12-09 Bio-Rad Laboratories, Inc. FXIII detection for verifying serum sample and sample size and for detecting dilution
US20070208163A1 (en) * 2003-07-10 2007-09-06 Novo Nordisk A/S Method for treatment of protein precipitates
WO2018111010A1 (ko) * 2016-12-14 2018-06-21 (주) 팬젠 항-혈액응고 제viii인자 항체 및 그 용도
US11155635B2 (en) 2016-12-14 2021-10-26 Pangen Biotech Inc. Anti-coagulation factor VIII antibody and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0087898A1 (en) * 1982-02-22 1983-09-07 Cancer Research Campaign Technology Limited Antibodies and antigens useful in the diagnosis and treatment of cancer
JPH01258700A (ja) * 1988-04-05 1989-10-16 Green Cross Corp:The 血液凝固第４因子の精製方法

Also Published As

Publication number Publication date
DE4127841A1 (de) 1993-02-25
KR100245542B1 (ko) 2000-02-15
ATE226595T1 (de) 2002-11-15
KR930004476A (ko) 1993-03-22
AU649868B2 (en) 1994-06-02
CA2076557C (en) 2007-05-01
AU2124692A (en) 1993-02-25
EP0529348B1 (de) 2002-10-23
DE59209970D1 (de) 2002-11-28
US5688919A (en) 1997-11-18
CA2076557A1 (en) 1993-02-23
JPH05268990A (ja) 1993-10-19
EP0529348A1 (de) 1993-03-03

Similar Documents

Publication Publication Date Title
DK0686177T3 (da) Fremgangsmåde til fremstilling af lineære olefiner med isomeriseret skelet
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
DK0454646T3 (da) System til rekonstruktion af led, især håndled
DE59209129D1 (de) Verwendung von Antikörper enthaltenden Präparationen zur Immunsuppression
MX9204546A (es) Proceso para la preparacion de natamicina por fermentacion.
SE8307023D0 (sv) Anordning for separation, foretredesvis av optiska isomerer, jemte forfarande for immobilisering av orosomucoid pa en berare och anvendning av denna for separation, foretredesvis av optiska isomerer
PT85490A (en) Process for the preparation of specific monoclonal antibodies of apolipoprotein-b and essay processes for the determination o the above mentioned apolipoprotein
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
MX9201430A (es) Procedimiento para la obtencion de pigmentos que contienen oxido cromico.
ES2183803T3 (es) Procedimiento para la purificacion de factor xiii, anticuerpos monoclonales contra factor xiiia, su preparacion y utilizacion.
DE68909579D1 (de) Methode zur steuerung des luft-kraftstoff-verhaeltnisses.
MX9204521A (es) Proceso para la preparacion de natamicina por fermentacion (caso ch-1898).
ES2113909T3 (es) Suero de control o calibracion, liquido y estable, para el diagnostico clinico.
MX9204520A (es) Proceso para la preparacion de natamicina por fermentacion (caso ch 2074).
DK0499157T3 (da) Fremgangsmåde til fremstilling af 1,3-dioxoler
DE59104867D1 (de) Alkoxysilylgruppen aufweisende Pyridiniumsalze.
NO874107L (no) Nye monoklonale antistoffer mot ifn-waa, fremgangsmaate til fremstilling derav og anvendelse for rensing samt paavisning av ifn-omega.
ATE41927T1 (de) Phenylalkylamine - bioregulatoren.
DK150083A (da) Fremgangsmaade til frembringelse af koncentreret biologisk isaer aktiveret slam
MX7196E (es) Procedimiento microbiologico para la preparacion de 1-carvona,a partir de 1-alfa-pineno o 1-beta-pineno
ATE155481T1 (de) Verfahren zur reinigung von streptolysin 0, intaktes streptolysin 0 erhältlich nach diesem verfahren und seine verwendung
DE3683178D1 (de) Methode zur herstellung monoklonaler antikoerper gegen plasminogenaktivatorfaktor.
DE59305781D1 (de) Halterung zur elastischen fixierung von langgestrecktem material, insbesondere von rohren
FR2679558B1 (fr) Procede de preparation de la cinnamoyl-13alpha baccatine iii ou desacetyl-10 baccatine iii.
AU3024289A (en) The use of monoclonal antibodies (mabs) as procedure control for immunometric assays